Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Progranulin precursor (GRN) encodes progranulin, a secreted, glycosylated protein composed of multiple tandem granulin/epithelin domains. It functions mainly as a growth factor involved in numerous biological processes, including cell proliferation, migration, wound healing, inflammation modulation, and lysosomal integrity. Progranulin is widely expressed, particularly in proliferative and immune cells, and is essential for normal embryonic and neural development. In lysosomes, it is cleaved to yield smaller, bioactive granulin peptides with diverse regulatory roles; individual fragments may act as either cell growth stimulators or inhibitors. Genetic loss-of-function mutations in GRN are directly linked to certain neurodegenerative diseases, such as frontotemporal dementia (FTD2) and neuronal ceroid lipofuscinosis (CLN11). Conversely, increased expression is implicated in cancer progression, especially breast and brain tumors. Therapeutic targeting of progranulin is being explored but presents challenges due to its dual roles in tumorigenesis and neuroprotection.
Growth factor-like mitogenic and cell survival signaling (promotes proliferation, migration, wound repair); Lysosomal enzyme activity modulation (helps regulate trafficking and acidification, impacts protease activity); Anti-inflammatory modulation (blocks TNF-mediated neutrophil activation; preserves neuronal integrity)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Progranulin precursor (GRN).